150 related articles for article (PubMed ID: 35493230)
1. Synthesis of 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: a way forward for targeting hypoxia and drug resistance of cancer cells.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Monzote L; Shchekotikhin AE
RSC Adv; 2021 Nov; 11(61):38782-38795. PubMed ID: 35493230
[TBL] [Abstract][Full Text] [Related]
2. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
3. Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity.
Buravchenko GI; Scherbakov AM; Korlukov AА; Dorovatovskii PV; Shchekotikhin AE
Curr Org Synth; 2020; 17(1):29-39. PubMed ID: 32103715
[TBL] [Abstract][Full Text] [Related]
4. Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells.
Scherbakov AM; Borunov AM; Buravchenko GI; Andreeva OE; Kudryavtsev IA; Dezhenkova LG; Shchekotikhin AE
Cancer Invest; 2018 Mar; 36(3):199-209. PubMed ID: 29624460
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives.
Sroor FM; Tohamy WM; Zoheir KMA; Abdelazeem NM; Mahrous KF; Ibrahim NS
BMC Chem; 2023 Aug; 17(1):106. PubMed ID: 37641068
[TBL] [Abstract][Full Text] [Related]
6. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
8. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of panaxadiol ester derivatives possessing pyrazole and pyrrole moiety as HIF-1α inibitors.
Lu YF; Liu C; Ma J; Piao HR; Zhang C; Jin X; Jin CH
Fitoterapia; 2024 Jun; 177():106052. PubMed ID: 38848978
[TBL] [Abstract][Full Text] [Related]
10. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
[TBL] [Abstract][Full Text] [Related]
11. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
[TBL] [Abstract][Full Text] [Related]
12. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.
Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM
Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors.
Wu YC; Lu MT; Lin TH; Chu PC; Chang CS
Bioorg Chem; 2022 Apr; 121():105681. PubMed ID: 35176558
[TBL] [Abstract][Full Text] [Related]
14. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic evaluation of certain 4-anilino-2-phenylquinoline derivatives.
Zhao YL; Chen YL; Chang FS; Tzeng CC
Eur J Med Chem; 2005 Aug; 40(8):792-7. PubMed ID: 16122581
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of Novel 8-Morpholinoimidazo[1,2-a]pyrazine Derivatives Bearing Phenylpyridine/Phenylpyrimidine-Carboxamides.
Xu S; Sun C; Chen C; Zheng P; Zhou Y; Zhou H; Zhu W
Molecules; 2017 Feb; 22(2):. PubMed ID: 28218676
[TBL] [Abstract][Full Text] [Related]
18. Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
Gervin E; Shin B; Opperman R; Cullen M; Feser R; Maiti S; Majumder M
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707933
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of novel series of 4-methoxy, and 4,9-dimethoxy-5-substituted furo[2,3-g]-1,2,3-benzoxathiazine-7,7-dioxide derivatives.
El-Sawy ER; Ebaid MS; Abo-Salem HM; El-Hallouty S; Kassem EM; Mandour AH
J Adv Res; 2014 May; 5(3):337-46. PubMed ID: 25685501
[TBL] [Abstract][Full Text] [Related]
20. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.
Doublier S; Belisario DC; Polimeni M; Annaratone L; Riganti C; Allia E; Ghigo D; Bosia A; Sapino A
BMC Cancer; 2012 Jan; 12():4. PubMed ID: 22217342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
